Black Diamond Therapeutics SG&A Expense (TTM) Trends

Black Diamond Therapeutics Inc (BDTX)

4.23 -0.18 (-4.08%) USD | NASDAQ | Sep 27, 16:00

4.24 +0.01 (+0.24%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2019. Upgrade now.

Date	Value
June 30, 2024	29.70M
March 31, 2024	27.00M
December 31, 2023	27.11M
September 30, 2023	28.79M
June 30, 2023	27.21M
March 31, 2023	27.31M
December 31, 2022	28.39M
September 30, 2022	27.56M
June 30, 2022	29.02M
March 31, 2022	30.04M

Date	Value
December 31, 2021	30.04M
September 30, 2021	29.05M
June 30, 2021	26.87M
March 31, 2021	23.73M
December 31, 2020	21.36M
September 30, 2020	18.82M
June 30, 2020	15.78M
March 31, 2020	12.28M
December 31, 2019	7.579M
September 30, 2019	5.362M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

5.362M

Minimum

Sep 2019

30.04M

Maximum

Dec 2021

23.65M

Average

27.16M

Median

SG&A Expense (TTM) Benchmarks